Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
ES9-17 REF: AN-AG021R6QCAS: 55854-43-8 | 98% | 127.00 €~576.00 € | Mon 13 May 24 | |
ES9-17 REF: TM-T64368CAS: 55854-43-8 | 99.81% | 54.00 €~402.00 € | Tue 14 May 24 | |
ES9-17 REF: 3D-BE170203CAS: 55854-43-8 | Min. 95% | 92.00 €~711.00 € | Wed 22 May 24 |
Ref: AN-AG021R6Q
25mg | 127.00 € | |
50mg | 152.00 € | |
100mg | 256.00 € | |
250mg | 576.00 € |
Estimated delivery in United States, on Monday 13 May 2024
ES9-17
CAS:55854-43-8
ES9-17, an analog of ES9 (endosidin9), is an inhibitor of clathrin-mediated endocytosis (CME). ES9-17 inhibits …
Formula:
C10H8BrNO2S2
Purity:
99.81%
Color and Shape:
Solid
Molecular weight:
318.21
Ref: TM-T64368
5mg | 54.00 € | |
10mg | 81.00 € | |
25mg | 124.00 € | |
50mg | 179.00 € | |
100mg | 269.00 € | |
200mg | 402.00 € | |
1ml*10 (DMSO) | 72.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
ES9-17
CAS:55854-43-8
Inhibitor of clathrin-mediated endocytosis (CME) and ligand to the clathrin heavy chain (CHC). ES9-17 is …
Formula:
C10H8BrNO2S2
Purity:
Min. 95%
Color and Shape:
Off-White Powder
Molecular weight:
318.21 g/mol
Ref: 3D-BE170203
10mg | 92.00 € | |
25mg | 175.00 € | |
50mg | 260.00 € | |
100mg | 431.00 € | |
250mg | 711.00 € |
Estimated delivery in United States, on Wednesday 22 May 2024